Augmedix Valuation
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Augmedix shows a prevailing Real Value of $1.69 per share. The current price of the firm is $2.35. Our model approximates the value of Augmedix from analyzing the firm fundamentals such as profit margin of (0.46) %, and Return On Equity of -3.3 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Augmedix's price fluctuation is somewhat reliable at this time. Calculation of the real value of Augmedix is based on 3 months time horizon. Increasing Augmedix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Augmedix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Augmedix Stock. However, Augmedix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.35 | Real 1.69 | Hype 2.35 | Naive 2.29 |
The intrinsic value of Augmedix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Augmedix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Augmedix helps investors to forecast how Augmedix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Augmedix more accurately as focusing exclusively on Augmedix's fundamentals will not take into account other important factors: Augmedix Total Value Analysis
Augmedix is presently forecasted to have valuation of 113.21 M with market capitalization of 116.16 M, debt of 25.85 M, and cash on hands of 29.99 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Augmedix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
113.21 M | 116.16 M | 25.85 M | 29.99 M |
Augmedix Investor Information
About 85.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.47. Augmedix had not issued any dividends in recent years. Based on the key measurements obtained from Augmedix's financial statements, Augmedix is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Augmedix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Augmedix has an asset utilization ratio of 67.24 percent. This suggests that the Company is making $0.67 for each dollar of assets. An increasing asset utilization means that Augmedix is more efficient with each dollar of assets it utilizes for everyday operations.Augmedix Ownership Allocation
Augmedix holds a total of 49.43 Million outstanding shares. The majority of Augmedix outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Augmedix to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Augmedix. Please pay attention to any change in the institutional holdings of Augmedix as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Augmedix Profitability Analysis
The company reported the previous year's revenue of 44.85 M. Net Loss for the year was (19.17 M) with profit before overhead, payroll, taxes, and interest of 13.95 M.About Augmedix Valuation
Our relative valuation model uses a comparative analysis of Augmedix. We calculate exposure to Augmedix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Augmedix's related companies.Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.
Augmedix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 43.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |